Rare essentials: drugs for rare diseases as essential medicines
Since 1977, the WHO Model List of Essential Medicines (EML), published by WHO, has provided advice for Member States that struggle to decide which pharmaceutical technologies should be provided to patients within their public health systems. Originating from outside WHO, an incentive system has been...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
The World Health Organization
2006-09-01
|
| Series: | Bulletin of the World Health Organization |
| Online Access: | http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S0042-96862006000900018&lng=en&tlng=en |